View all IQVIA events


Risk-based Monitoring (RBM) continues its transformation of clinical monitoring, and many leading pharma firms are realizing its benefits – while many others are just beginning to look at RBM for their trials.
IQVIA, the RBM market leader, will share insights from years of executing RBM trials, from different phases and various therapeutic areas, including
You will also hear the latest enhancements and new capabilities including predictive and advanced analytics that are driving new levels of efficiencies in clinical development.
Key take-aways: